Title: RNA Interference-mediating Small RNA Molecules
Patent Number: 8,853,384
Filed: Dec. 2, 2009
Lead Inventor: Thomas Tuschl, Max Planck Institute
Title: Transgenic Plant-based Methods for Plant Pests Using RNAi
Patent Number: 8,853,489
Filed: Sept.18, 2006
Lead Inventor: Romaan Raemaekers, Devgen (Syngenta)
Title: Lipid-formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
Patent Number: 8,859,516
Filed: Sept.10, 2010
Lead Inventor: David Bumcrot, Alnylam Pharmaceuticals
Title: Methods Targeting miR-33 microRNAs for Regulating Lipid Metabolism
Patent Number: 8,859,519
Filed: Aug. 25, 2011
Inventor: Anders Naar, Harvard Medical School
Title: Oligomeric Compounds and Compositions for Use in Modulation of Small, Non-coding RNAs
Patent Number: 8,859,521
Filed: Dec. 30, 2013
Lead Inventor: Frank Bennett, Regulus Therapeutics
Title: Use of RNAi Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
Patent Number: 8,859,562
Filed: Sept. 15, 2006
Inventor: Thomas Helleday, University of Sheffield
Title: Modified Short Interfering RNA
Patent Number: 8,859,749
Filed: March 8, 2006
Lead Inventor: Ioanna Andreou, Qiagen
Title: RNAi Modulation of RSV and Therapeutic Uses Thereof
Patent Number: 8,859,750
Filed: March 29, 2012
Lead Inventor: Rachel Meyers, Alnylam Pharmaceuticals
Title: Oligonucleotide Compounds Comprising Non-nucleotide Overhangs
Patent Number: 8,859,751
Filed: Jan. 6, 2012
Lead Inventor: Sharon Nachum, Quark Pharmaceuticals
Title: siRNA-based Therapy of Fibrodysplasia Ossificans Progressiva
Patent Number: 8,859,752
Filed: Oct. 17, 2012
Lead Inventor: Frederick Kaplan, University of Pennsylvania